Pioneering bacterial infection treatment with theranostics

We are focused on the development of localized theranostic solutions that completely change the way bacterial infections are diagnosed and treated. Combine precision imaging with targeted interventions to improve patient outcomes.

Sabiad doctor holding StaphMark vial for theranostics in bacterial infection management

Meet Our Partners

Pharma Connect Capital Logo
Venn Life Sciences Logo
TVH Business Consultancy BV Logo
UMCG Groningen Logo
Rijksdienst voor Ondernemend Nederland logo
NWO logo

Experts in theranostics for bacterial infections

Sabiad team members Prof. Dr. Paul Jutte, Prof. Dr. Jan Maarten van Dijl, and Saskia van den Dool in an office setting, representing leadership in theranostics for bacterial infections.

Sabiad BV was founded as a spin-off from the University Medical Center Groningen (UMCG) to commercialize two decades of research into staphylococcal surface proteins by Prof. Jan Maarten van Dijl. We aim to transform the detection and treatment of bacterial infections with a tracer based on the 1D9 antibody, with a focus on Staphylococcus aureus (SA) infections.

“At Sabiad, we believe that infection management should be as precise and effective as possible.”

Challenge

The growing threat of Staphylococcus Aureus infections

Surgical infections caused by Staphylococcus aureus (SA) are becoming harder to manage, particularly in joint replacements and fracture repairs. These infections often evade treatment, leading to prolonged hospital stays and increased healthcare costs.

Hard-to-diagnose infections often form biofilms that shield them from treatment, prolonging bacterial infection treatment and raising costs.

Our 1D9 antibody targets infections with pinpoint precision, disrupting biofilms and enabling early intervention.

3D rendering of Staphylococcus bacteria in purple, illustrating the focus on bacterial infection treatment.
Our Approach

Next-Gen bacterial infection treatment with StaphMark

Our patented StaphMark technology sets the gold standard for bacterial infection diagnosis & treatment. It accurately identifies infections in real-time, and then uses targeted therapy to tackle the infection directly, while protecting surrounding healthy tissue.

Pastel hourglass icon

Real-time detection

Real-time detection of bacterial infections with StaphMark solution.

Pastel target icon

Targeted treatments

Targeted treatments that focus on infections, protecting healthy tissues.

Broken chain icon

Biofilm disruption

Disrupts biofilms effectively, reducing the chances of infection recurrence.

No antibiotics icon

Localized therapies

Localized therapies that reduce reliance on broad-spectrum antibiotics.

Improve bacterial treatment at every stage

At Sabiad, we revolutionize bacterial infection treatment by combining precise diagnostics with powerful therapies. We address infections like Staphylococcus aureus at their source—quickly, effectively, and with a personalized touch.

Fast & accurate diagnosis
Targeted therapy
Disrupts biofilms
Lowers dependence on antibiotics
Innovative In vivo and ex vivo applications

See how Sabiad helps key stakeholders manage bacterial infections

Our theranostic solutions are designed to benefit a wide range of healthcare professionals, offering real-time precision and targeted treatment for bacterial infections.

Here’s how Sabiad supports different roles in healthcare:

Infectious disease specialists

Improve treatment outcomes by targeting bacterial infections with precision therapies.

Orthopedic Surgeons

Make quicker, data-driven treatment decisions with real-time diagnostic insights.

Hospital administrator

Reduce costs by preventing infections, cutting antibiotic use, and minimizing re-admissions.

Clinicians

Make quicker, data-driven treatment decisions with real-time diagnostic insights.

Infectious disease specialists

Improve treatment outcomes by targeting bacterial infections with precision therapies.

Surgeons

Access real-time infection data during surgery to reduce complications and improve healing.

Hospital administrator

Reduce costs by preventing infections, cutting antibiotic use, and minimizing re-admissions.

Sabiad Logomark
Research

Explore the latest in infection research field of bacterial infection theranostics

Human antibody protection against staphylococcus aureus
Van den Berg S et al., 2015
Epitope recognition in Staphylococcal antigen A
Koedijk DGAM et al., 2017
Noninvasive imaging of Staphylococcus infections
Romero Pastrana F et al., 2018

Frequently Asked Questions

Illustration of a female doctor with a questioning expression, symbolizing inquiry in a Frequently Asked Questions section.

Theranostics combines diagnostic and therapeutic capabilities in a single platform, allowing for precise detection and targeted treatment of diseases like bacterial infections. It enables real-time identification of infections and immediate, tailored interventions.

By targeting infections directly and accurately, theranostic technologies reduce the need for broad-spectrum antibiotics, which helps slow down the development of antibiotic-resistant bacteria.

Early detection often relies on advanced imaging, rapid diagnostics, and blood tests. Real-time diagnostic tools, like those used in theranostics, can detect infections early, even in challenging environments like biofilms.

If left untreated, bacterial infections can spread, leading to more severe complications, such as sepsis, organ damage, or in severe cases, death. Early detection and treatment are essential for effective management.

Sabiad develops advanced solutions that focus on precision diagnostics and treatments for bacterial infections. By combining cutting-edge research with theranostic platforms, we help clinicians identify and treat infections more effectively.